| Product NDC: | 53808-0810 | 
| Proprietary Name: | Viread | 
| Non Proprietary Name: | tenofovir disoproxil fumarate | 
| Active Ingredient(s): | 300 mg/1 & nbsp; tenofovir disoproxil fumarate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 53808-0810 | 
| Labeler Name: | State of Florida DOH Central Pharmacy | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021356 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20090701 | 
| Package NDC: | 53808-0810-1 | 
| Package Description: | 30 TABLET, COATED in 1 BLISTER PACK (53808-0810-1) | 
| NDC Code | 53808-0810-1 | 
| Proprietary Name | Viread | 
| Package Description | 30 TABLET, COATED in 1 BLISTER PACK (53808-0810-1) | 
| Product NDC | 53808-0810 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | tenofovir disoproxil fumarate | 
| Dosage Form Name | TABLET, COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20090701 | 
| Marketing Category Name | NDA | 
| Labeler Name | State of Florida DOH Central Pharmacy | 
| Substance Name | TENOFOVIR DISOPROXIL FUMARATE | 
| Strength Number | 300 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |